Home / Sumatriptan / Canada
CA ATC N02CC01 · updated 2 Nov 2026
Sumatriptan shortage in Canada
Is there a Sumatriptan shortage in Canada?
Yes. As of 2 Nov 2026, 4 Sumatriptan products are reported short in Canada, the first since 20 Jul 2026. The company estimate for the return is 7 Nov 2026 (latest 9 Feb 2027). Main reason: manufacturing problem.
Also short in Germany, Italy, Spain, Ireland, Austria, Belgium, Czechia, Norway, Sweden, Japan, New Zealand, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | MYLAN-SUMATRIPTAN (6BL) | MYLAN PHARMACEUTICALS ULC | 20 Jul 2026 | 9 Feb 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MYLAN-SUMATRIPTAN (6BL) | MYLAN PHARMACEUTICALS ULC | 21 Sep 2026 | 9 Feb 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | IMITREX (2's) | GLAXOSMITHKLINE INC | 22 Oct 2026 | 7 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | SUMATRIPTAN (6) anticipated | SANIS HEALTH INC | 20 Nov 2026 | 29 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.